Literature DB >> 17234155

Bone marrow stromal cells stimulate neurite outgrowth over neural proteoglycans (CSPG), myelin associated glycoprotein and Nogo-A.

Karina T Wright1, Wagih El Masri, Aheed Osman, Sally Roberts, Giselle Chamberlain, Brian A Ashton, William E B Johnson.   

Abstract

In animal models, transplantation of bone marrow stromal cells (MSC) into the spinal cord following injury enhances axonal regeneration and promotes functional recovery. How these improvements come about is currently unclear. We have examined the interaction of MSC with neurons, using an established in vitro model of nerve growth, in the presence of substrate-bound extracellular molecules that are thought to inhibit axonal regeneration, i.e., neural proteoglycans (CSPG), myelin associated glycoprotein (MAG) and Nogo-A. Each of these molecules repelled neurite outgrowth from dorsal root ganglia (DRG) in a concentration-dependent manner. However, these nerve-inhibitory effects were much reduced in MSC/DRG co-cultures. Video microscopy demonstrated that MSC acted as "cellular bridges" and also "towed" neurites over the nerve-inhibitory substrates. Whereas conditioned medium from MSC cultures stimulated DRG neurite outgrowth over type I collagen, it did not promote outgrowth over CSPG, MAG or Nogo-A. These findings suggest that MSC transplantation may promote axonal regeneration both by stimulating nerve growth via secreted factors and also by reducing the nerve-inhibitory effects of the extracellular molecules present.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17234155     DOI: 10.1016/j.bbrc.2007.01.013

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

1.  Preferential cell response to anisotropic electro-spun fibrous scaffolds under tension-free conditions.

Authors:  A English; A Azeem; D A Gaspar; K Keane; P Kumar; M Keeney; N Rooney; A Pandit; D I Zeugolis
Journal:  J Mater Sci Mater Med       Date:  2011-11-22       Impact factor: 3.896

2.  Immunosuppression of allogenic mesenchymal stem cells transplantation after spinal cord injury improves graft survival and beneficial outcomes.

Authors:  Abel Torres-Espín; Elena Redondo-Castro; Joaquim Hernandez; Xavier Navarro
Journal:  J Neurotrauma       Date:  2015-01-22       Impact factor: 5.269

3.  Transplantation of mesenchymal stem cells promotes an alternative pathway of macrophage activation and functional recovery after spinal cord injury.

Authors:  Hideaki Nakajima; Kenzo Uchida; Alexander Rodriguez Guerrero; Shuji Watanabe; Daisuke Sugita; Naoto Takeura; Ai Yoshida; Guang Long; Karina T Wright; William E B Johnson; Hisatoshi Baba
Journal:  J Neurotrauma       Date:  2012-04-18       Impact factor: 5.269

Review 4.  The developing landscape of diagnostic and prognostic biomarkers for spinal cord injury in cerebrospinal fluid and blood.

Authors:  C H Hulme; S J Brown; H R Fuller; J Riddell; A Osman; J Chowdhury; N Kumar; W E Johnson; K T Wright
Journal:  Spinal Cord       Date:  2016-12-20       Impact factor: 2.772

5.  Bridging defects in chronic spinal cord injury using peripheral nerve grafts combined with a chitosan-laminin scaffold and enhancing regeneration through them by co-transplantation with bone-marrow-derived mesenchymal stem cells: case series of 14 patients.

Authors:  Sherif M Amr; Ashraf Gouda; Wael T Koptan; Ahmad A Galal; Dina Sabry Abdel-Fattah; Laila A Rashed; Hazem M Atta; Mohammad T Abdel-Aziz
Journal:  J Spinal Cord Med       Date:  2013-11-26       Impact factor: 1.985

Review 6.  Mesenchymal stem cells secretome: a new paradigm for central nervous system regeneration?

Authors:  Fábio G Teixeira; Miguel M Carvalho; Nuno Sousa; António J Salgado
Journal:  Cell Mol Life Sci       Date:  2013-03-01       Impact factor: 9.261

7.  Delayed transplantation of human marrow stromal cell-seeded scaffolds increases transcallosal neural fiber length, angiogenesis, and hippocampal neuronal survival and improves functional outcome after traumatic brain injury in rats.

Authors:  Ye Xiong; Changsheng Qu; Asim Mahmood; Zhongwu Liu; Ruizhuo Ning; Yi Li; David L Kaplan; Timothy Schallert; Michael Chopp
Journal:  Brain Res       Date:  2009-01-30       Impact factor: 3.252

8.  The effects of canine bone marrow stromal cells on neuritogenesis from dorsal root ganglion neurons in vitro.

Authors:  Hiroaki Kamishina; Jennifer A Cheeseman; Roger M Clemmons
Journal:  Vet Res Commun       Date:  2009-03-03       Impact factor: 2.459

Review 9.  Concise review: Bone marrow for the treatment of spinal cord injury: mechanisms and clinical applications.

Authors:  Karina T Wright; Wagih El Masri; Aheed Osman; Joy Chowdhury; William E B Johnson
Journal:  Stem Cells       Date:  2011-02       Impact factor: 6.277

10.  Effects of bone marrow stromal cell transplantation through CSF on the subacute and chronic spinal cord injury in rats.

Authors:  Norihiko Nakano; Yoshiyasu Nakai; Tae-Beom Seo; Tamami Homma; Yoshihiro Yamada; Masayoshi Ohta; Yoshihisa Suzuki; Toshio Nakatani; Masanori Fukushima; Miki Hayashibe; Chizuka Ide
Journal:  PLoS One       Date:  2013-09-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.